Diabetes is a significant predictor of adverse cardiovascular events following percutaneous coronary intervention (PCI). However, comprehensive data on very long-term outcomes in the era of drug-eluting stents (DES) is still limited.
To assess the impact of diabetes on clinical outcomes after PCI with DES...
M. I. Molaro, F. Simonetti, T. Lenz et al.· European Heart Journal· 0 citations
Patients treated with percutaneous coronary intervention (PCI) for bifurcation lesions have an increased risk of recurrent cardiac events. However, there are limited data on long-term outcomes after PCI with drug-eluting stents (DES) for bifurcation lesions. We sought to compare the long-term outcomes after DES PCI for...
Constantin Kuna, Laura Huber, J. Coughlan et al.· Cardiovascular Intervention...· 0 citations
Background Atrial fibrillation (AF) is associated with an increased risk of ischemic stroke, primarily originating from the left atrial appendage (LAA). Percutaneous LAA closure (LAAC) reduces appendage-borne thromboembolism, while pulmonary vein isolation (PVI) restores sinus rhythm. Observational data on the combined...
Isabel Rattka, Christine M. Poch, Tanja Mews et al.· International Journal of Car...· 0 citations
It is suggested that even modest levels of base editing-mediated exon skipping may ameliorate the DMD cardiac phenotype toward a BMD-like state, supporting the translational potential of this dual rAAV base editing approach for DMD cardiomyopathy.
Ina Luksch, Christine M. Poch, Aylin Mayer et al.· Human Gene Therapy· 0 citations
Combined CA + LAAC was associated with significantly higher arrhythmia recurrence than CA-only, potentially attributable to limited substrate modification in the one-stop setting.
Isabel Rattka, Christine M. Poch, Tabea Deichsel et al.· Journal of interventional ca...· 1 citation
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.